Complete the short form below to become a member of Oncology Central for free today to access this panel discussion. 

Gain an understanding of how oncologists are treating non-metastatic castration-resistant prostate cancer (CRPC) in our latest panel discussion, featuring experts insights from Catherine Marshall and Channing Paller (Johns Hopkins School of Medicine, MD, USA) and Judd Moul (Duke University Medical Center, NC, USA).

The panelists discuss the past, present and future of the treatment landscape for non-metastatic CRPC, and detail the treatments and sequencing used in their own practice. Marshall, Paller and Moul also present their own case studies and discuss how they would approach each other's cases.

Complete the form below to become a member of Oncology Central and access your FREE panel discussion! If you’re already a member, your details should be pre-filled so you can view the panel discussion even quicker!